Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • riskreturn168 riskreturn168 Jun 9, 2014 12:34 AM Flag

    Copenhagen is Gerald's Centerpiece

    There will be catalysts before and after the mid July AD Conference in Copenhagen, but Copenhagen is the centerpiece. It is where Gerald introduces LymPro to the world and releases data! From Copenhagen there will be a countdown to LymPro commercialization, which will probably be less than 90 days. LymPro's commercial launch and AMBS' launch to the NASDAQ are interrelated and will happen around the same time. (Octoberish?) To the extent he can I wouldn't be surprised if Gerald is choreographing the timing of each catalyst in order to reach the highest pps pinnacle prior to up listing. Catalysts released before and after Copenhagen will include: Wolfram's data, Retinitis functionality data, MANF/Wolframs and MANF/Retinitis and Eltoprazine orphan status, possible partnerships for MANF indications as well as Eltoprazine, GDNF results on their Phase 2 trial (effecting MANF PD), MANF toxicaology report, LymPro Revenue Guidance, LymPro Commercialization, the beginning of Eltoprazine clinical phase 2b/3 trial, LymPro/Concussion testing results, announcement of up listing, positions taken by JP Morgan, Fidelity, and BofA, etc, and maybe even the Goose that lays the golden egg........announcements of Phenoguard discoveries!! Gerald is going to synchronize these catalysts and Lincoln Park is going to help him CAPITALIZE!! Hang on to your shares until way after the New Year!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMBS
0.0501-0.0044(-8.07%)May 22 3:59 PMEDT